Bristol Myers Squibb (CELG-RI) Acquisitions (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 16 years of Acquisitions data on file, last reported at $65.0 million in Q1 2026.

• Acquisitions for Q1 2026 came in at $65.0 million, down 16.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 billion (up 112.95% YoY), and the FY2025 annual result was $3.9 billion, down 81.93% from the prior year.
• Acquisitions retreated to $65.0 million in Q1 2026 per CELG-RI's latest filing, from $1.7 billion in the prior quarter.
• Over five years, Acquisitions peaked at $20.1 billion in Q1 2024 and troughed at $47.0 million in Q4 2024.
• A 5-year average of $1.8 billion and a median of $348.0 million in 2024 frame the typical range for Acquisitions.
• The sharpest annual moves came in 2024 and 2025: Acquisitions jumped 25608.97% in 2024, then slumped 99.61% in 2025.
• A 5-year view of Acquisitions shows it stood at $116.0 million in 2022, then jumped by 400.86% to $581.0 million in 2023, then plunged by 91.91% to $47.0 million in 2024, then jumped by 3531.91% to $1.7 billion in 2025, then slumped by 96.19% to $65.0 million in 2026.
• Business Quant data shows CELG-RI's Acquisitions at $65.0 million in Q1 2026, $1.7 billion in Q4 2025, and $1.9 billion in Q3 2025.